Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 480,500
-53,500 (-10.02%)
At close: Oct 8, 2026
Hanmi Pharm. Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,655,479 | 1,547,531 | 1,495,502 | 1,490,887 | 1,331,547 | 1,203,186 |
Revenue Growth | 12.93% | 3.48% | 0.31% | 11.97% | 10.67% | 11.83% |
Gross Profit Gross Profit Growth | 986,573 | 884,407 | 817,037 | 829,249 | 718,553 | 632,752 |
Operating Income Operating Income Growth | 276,237 | 223,870 | 212,511 | 224,885 | 153,896 | 125,416 |
Net Income Net Income Growth | 217,045 | 169,554 | 121,315 | 146,231 | 82,792 | 67,025 |
Earnings Per Share EPS Growth | 17098.38 | 13362.00 | 9566.83 | 11522.12 | 6517.33 | 5269.87 |
EPS Growth | 101.95% | 39.67% | -16.97% | 76.79% | 23.67% | 461.07% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Reconciliation of Inter-Sector Transactions Reconciliation of Inter-Sector Transactions Growth | -89,431 | -92,766 | -113,143 | -114,815 | -101,689 | -89,719 |
Overseas Pharmaceuticals Overseas Pharmaceuticals Growth | 386,362 | 402,395 | 385,630 | 397,690 | 350,640 | 288,729 |
Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients Growth | 91,179 | 91,280 | 108,892 | 111,067 | 100,547 | 87,158 |
Medicine Medicine Growth | 1,267,369 | 1,146,622 | 1,114,123 | 1,096,946 | 982,049 | 917,018 |
Total Total Growth | 1,655,479 | 1,547,531 | 1,495,502 | 1,490,887 | 1,331,547 | 1,203,186 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 409,309 | 201,322 | 193,195 | 255,183 | 236,736 | 211,734 |
Total Debt Total Debt Growth | 417,859 | 434,211 | 496,687 | 572,867 | 678,323 | 756,267 |
Net Cash (Debt) Net Cash Growth | -8,550 | -232,889 | -303,492 | -317,685 | -441,586 | -544,532 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -673.78 | -18353.48 | -23933.19 | -25031.60 | -34761.50 | -42813.87 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 272,895 | 173,072 | 193,487 | 216,538 | 162,269 | 201,923 |
Capital Expenditures CapEx Growth | -56,518 | -43,025 | -39,261 | -27,352 | -30,378 | -19,949 |
Free Cash Flow Free Cash Flow Growth | 216,378 | 130,048 | 154,226 | 189,186 | 131,890 | 181,974 |
Free Cash Flow Growth | 97.75% | -15.68% | -18.48% | 43.44% | -27.52% | 65.85% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 59.59% | 57.15% | 54.63% | 55.62% | 53.96% | 52.59% |
Operating Margin | 16.69% | 14.47% | 14.21% | 15.08% | 11.56% | 10.42% |
Pretax Margin | 17.29% | 13.79% | 11.45% | 13.01% | 9.09% | 8.62% |
Profit Margin | 13.11% | 10.96% | 8.11% | 9.81% | 6.22% | 5.57% |
FCF Margin | 13.07% | 8.40% | 10.31% | 12.69% | 9.90% | 15.12% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Oct '26 Oct 10, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 2000.000 | 2000.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.42% | 0.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.10 | 33.80 | 29.32 | 30.59 | 44.83 | 50.34 |
Forward PE | 26.81 | 33.64 | 19.54 | 30.57 | 38.01 | 44.63 |
P/FCF Ratio | 28.18 | 44.07 | 23.06 | 23.65 | 28.14 | 18.54 |
PS Ratio | 3.68 | 3.70 | 2.38 | 3.00 | 2.79 | 2.80 |